MPM Capital Limited Partnership

MPM Capital Limited Partnership

MPM Capital Limited Partnership firm targets biotechnology, specialty pharmaceutical, and medical technology companies. With more than $2 billion of committed capital in four funds, it invests in all stages of a firm's development, typically offering between $5 million and $50 million per transaction, and takes a long-term approach. MPM Capital's portfolio includes about 60 firms, including Affymax, AVEO Pharmaceuticals, Oxagen, and Surface Logix. Most of MPM Capital's investments are in US concerns, but the company also seeks opportunities in Europe, and more recently, Asia and Australia.

Contact Details

Office Address

MPM Capital Limited Partnership
The John Hancock Tower, 200 Clarendon Street
54th floor
Boston, MA, USA 02116
Phone: (617) 425-9200
Fax: (617) 425-9201

Executives

Chairman and Venture Partner

H. Robert Horvitz

Director Operations and Legal Affairs

Dana K. O'Brien

Business Reviews for MPM Capital Limited Partnership

Related Companies